References
- 1 Der Kuil WA, Schoffelen AF, Greeff SC De, Thijsen SFT, Alblas HJ, Notermans DW. National laboratory-based surveillance system for antimicrobial resistance : a successful tool to support the control of antimicrobial resistance in the Netherlands. Euro Surveill. 2017;22(46):17-00062. DOI: 10.2807/1560-7917. ES.2017.22.46.17-00062
- 2. Poirel L, Pitout JD, Nordmann P. Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol. 2007; Vol. 2: 501-12. DOI: 10.2217/17460913.2.5.50117927473
- 3. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791-8. DOI: 10.3201/eid1710.110655331068222000347
- 4. Sadek M, Demord A, Poirel L, Nordmann P. Fast and reliable detection of carbapenemase genes in various Gram negatives using a new commercially available fluorescence-based real-time polymerase chain reaction platform. Diagn Microbiol Infect Dis [Internet]. 2020;98(3):115127. DOI: 10.1016/j.diagmicrobio.2020.11512732731095
- 5. Muntean D, Horhat FG, Badiţoiu L, Dumitraşcu V, Bagiu IC, Horhat DI, et al. Multidrug-resistant gram-negative bacilli: A retrospective study of trends in a tertiary healthcare unit. Med. 2018;54(6). DOI: 10.3390/medicina54060092630707830486311
- 6. Musuroi C, Licker M, Rus M, Seclaman E, Muntean D, Vulpie S, et al. Difficult to Treat Proteeae strains in high risk Romanian hospital departments. Rev Rom Med Lab. 2021;29(1):53-64. DOI: 10.2478/rrlm-2021-0003
- 7. Tompa M, Pandrea SL, Tompa R, Iancu M, Junie LM. Phenotypic detection of Carbapenem-resistant Klebsi-ella pneumoniae strains isolated from blood cultures. HVM Bioflux. 2021;13(1):40-6.
- 8. European Committee on Antimicrobial. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2017;Version 7.1:0-77. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EU-CAST_files/Breakpoint_tables/v_7.1_Breakpoint_Tables.pdf
- 9. Skov R, Skov G. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and /or epidemiological importance. 2017;(December):1-47.
- 10. Dolinsky AL. M100 Performance Standards for Antimicrobial Susceptibility Testing [Internet]. J Serv Mark. 2017; Vol. 8:27-39. DOI: 10.1108/08876049410065598
- 11. Roche Diagnostics GmbH. High Pure PCR Template Preparation Kit. 2008;(11):1-26. Available from: www. roche-applied-science.com (Accessed 20th september 2018).
- 12. Roche. LightCycler ® Multiplex DNA Master HypProbe. Roche [Internet]. 2016;(11):1-18. Available from: https://www.n-genetics.com/products/1295/1023/14284.pdf (Accessed 19th September 2018)
- 13. Red L. LightMix Universal Color Compensation Hexaplex Version. 2016;V160606: 4-11. Available from: https://www.roche-as.es/lm_pdf/LightMix_40-0320_CC_ColorCompensation_Hexaplex_V160606.pdf (Accessed 18th September 2018)
- 14. Tib Molbiol. LightMix Modular OXA-48 Carbapenemase. 2018; Version180101 (58):1-4. available from: https://www.roche-as.es/lm_pdf/MDx_58_0628_96_OXA_48_Carbapenemase_BR_EN_FR_ES_IT_DE_PT.pdf (Accessed 19th september 2018)
- 15. Jones RN, Flonta M, Gurler N, Cepparulo M, Mendes RE, Castanheira M. Resistance surveillance program report for selected European nations (2011). Diagn Microbiol Infect Dis [Internet]. 2014;78(4):429-36. DOI: 10.1016/j.diagmicrobio.2013.10.00824440509
- 16. Székely E, Damjanova I, Jánvári L, Vas KE, Molnár S, Bilca D V., et al. First description of blaNDM-1, blaOXA-48, blaOXA-181 producing Enterobacteriaceae strains in Romania. Int J Med Microbiol. 2013;303(8):697-700. DOI: 10.1016/j.ijmm.2013.10.00124183483
- 17. Gheorghe I, Czobor I, Chifiriuc MC, Borcan E, Ghiţă C, Banu O, et al. Molecular screening of carbapenemase-producing Gram-negative strains in Romanian intensive care units during a one year survey. J Med Microbiol. 2014;63:1303-10. DOI: 10.1099/jmm.0.074039-025060972
- 18. Rafila A, Talapan D, Dorobăţ OM, Popescu GA, Piţigoi D, Florea D, et al. Emergence of Carbapenemase-producing Enterobacteriaceae, a Public Health Threat: a Romanian Infectious Disease Hospital Based Study. Rev Rom Med Lab. 2015;23(3):295-302. DOI: 10.1515/rrlm-2015-0024
- 19. Lixandru BE, Cotar AI, Straut M, Usein CR, Cristea D, Ciontea S, et al. Carbapenemase-producing klebsiella pneumoniae in Romania: A six-month survey. PLoS One. 2015;10(11):1-10. DOI: 10.1371/journal. pone.0143214
- 20. Főldes A, Bilca DV, Székely E. Phenotypic and molecular identification of carbapenemase-producing enterobacteriaceae- challenges in diagnosis and treatment. Rev Rom Med Lab. 2018;26(2):221-30. DOI: 10.2478/rrlm-2018-0018
- 21. Lopes E, Saavedra MJ, Costa E, de Lencastre H, Poirel L, Aires-de-Sousa M. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in northern Portugal: Predominance of KPC-2 and OXA-48. J Glob Antimicrob Resist [Internet]. 2020;22:349-53. Available from: DOI: 10.1016/j.jgar.2020.04.007 DOI: 10.1016/j.jgar.2020.04.00732348902
- 22. Haldorsen B, Giske CG, Hansen DS, Helgason KO, Kahlmeter G, Löhr IH, et al. Performance of the EU-CAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: The NordicAST CPE study. J Antimicrob Chemother. 2018;73(10):2738-47. DOI: 10.1093/jac/dky276614832430053113
- 23. Bartolini A, Frasson I, Cavallaro A, Richter SN, Palù G. Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae. Gut Pathog. 2014;6(1):1-7. DOI: 10.1186/1757-4749-6-13403258424860620
- 24. Ovia-o M, Torres I, González M, Bou G. Evaluation of a novel procedure for rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) using the LightMix modular carbapenemase kits. J Antimicrob Chemother. 2016;71(12):3420-3. DOI: 10.1093/jac/dkw356540007827566313
- 25. Yoshioka N, Hagiya H, Deguchi M, Hamaguchi S, Kagita M, Nishi I, et al. Multiplex Real-Time PCR Assay for Six Major Carbapenemase Genes. Pathogens. 2021;10(3):276. DOI: 10.3390/pathogens10030276799984133804402